Tiny Gold Nanoparticles Show Promise For Early Parkinson's Disease Detection: Study Suggests

Published On 2025-09-01 02:45 GMT   |   Update On 2025-09-01 09:34 GMT
Advertisement

A recent study published in the Nanoscale journal (Royal Society of Chemistry) reveals a promising nanotechnology-based tool for the early detection of Parkinson's Disease (PD), led by Dr. Sharmistha Sinha at the Institute of Nano Science and Technology (INST), Mohali.

Parkinson’s, one of the fastest-growing neurological disorders globally, is projected to affect a growing number of people in India due to an aging population, creating a heavy burden on healthcare systems. Early diagnosis remains a challenge, as most cases are identified only after significant brain damage has occurred.

The research focused on detecting harmful changes in a protein called α-synuclein, known to be linked with PD. This protein transforms from a harmless form to toxic aggregates that damage brain cells. The team developed gold nanoclusters (AuNCs)—tiny, glowing particles only a few nanometers wide—coated with amino acids to selectively bind either the normal or toxic protein forms. Proline-coated clusters bound to the normal protein, while histidine-coated clusters attached to the toxic aggregates, enabling clear differentiation.

Advertisement

The scientists engineered and purified both normal and mutant forms of α-synuclein, then characterized the nanoclusters using advanced techniques such as UV-Vis spectroscopy, electron microscopy, and electrochemical methods. They tested the biosensor’s effectiveness in human neuroblastoma cells to confirm its safety and function in biological conditions.

Dr. Sinha emphasized that this label-free, cost-effective, and clinically adaptable platform could enable point-of-care diagnostics for PD, allowing early intervention and improved patient outcomes. The approach may extend to detecting other protein-misfolding diseases like Alzheimer’s, potentially transforming neurological disease management worldwide. This collaborative effort highlights how innovative nanotechnology can revolutionize early disease detection.

Reference: Harpreet Kaur, Arpit Tyagi, Ishani Sharma, Deepak Sharma, Sharmistha Sinha; Differentiating α-synuclein aggregates using charge-sensitive gold nanoclusters; Nanoscale -Royal Society of Chemistry; https://doi.org/10.1039/D5NR00887E

Full View
Tags:    
Article Source : Nanoscale

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News